title: Isolation of multiple drug-resistant enteric bacteria from feces of wild Western Lowland Gorilla (Gorilla gorilla gorilla) in Gabon.
abstract: Prevalence of drug-resistant bacteria in wildlife can reveal the actual level of anthropological burden on the wildlife. In this study, we isolated two multiple drug-resistant strains, GG6-2 and GG6-1-1, from 27 fresh feces of wild western lowland gorillas in Moukalaba-Doudou National Park, Gabon. Isolates were identified as Achromobacter xylosoxidans and Providencia sp., respectively. Minimum inhibitory concentrations of the following 12 drugs-ampicillin (ABPC), cefazolin (CEZ), cefotaxime (CTX), streptomycin (SM), gentamicin (GM), kanamycin (KM), tetracycline (TC), nalidixic acid (NA), ciprofloxacin (CPFX), colistin (CL), chloramphenicol (CP) and trimethoprim (TMP)-were determined. Isolate GG6-2 was resistant to all antimicrobials tested and highly resistant to CTX, SM, TC, NA and TMP. Isolate GG6-1-1 was resistant to ABPC, CEZ, TC, CL, CP and TMP.
authors: Research Institute of Tropical Ecology, Libreville, Bp 13354, Libreville, Gabon.
authors: Pierre Philippe
authors: PP
authors: Mbehang Nguema
authors: Torahiko
authors: T
authors: Okubo
authors: Sayaka
authors: S
authors: Tsuchida
authors: Shiho
authors: S
authors: Fujita
authors: Juichi
authors: J
authors: Yamagiwa
authors: Yutaka
authors: Y
authors: Tamura
authors: Kazunari
authors: K
authors: Ushida
mesh_terms: D042441:Achromobacter denitrificans / Q000187:drug effects* / Q000302:isolation & purification; D000818:Animals; D000835:Animals, Wild; D024901:Drug Resistance, Multiple, Bacterial; D005243:Feces / Q000382:microbiology*; D005681:Gabon / Q000453:epidemiology; D006071:Gorilla gorilla / Q000382:microbiology*; D011532:Providencia / Q000187:drug effects* / Q000302:isolation & purification
references: J Clin Microbiol. 2002 Jun;40(6):2153-62
references: 12037080
references: J Gen Appl Microbiol. 2002 Jun;48(3):143-54
references: 12469297
references: Am J Trop Med Hyg. 2003 Oct;69(4):406-10
references: 14640501
references: Cancer. 2004 Nov 1;101(9):2134-40
references: 15389476
references: Science. 1992 Aug 21;257(5073):1050-5
references: 1509255
references: Appl Environ Microbiol. 1998 Feb;64(2):795-9
references: 9464425
references: J Med Microbiol. 1998 Jul;47(7):629-42
references: 9839568
references: Emerg Infect Dis. 2005 Jun;11(6):935-8
references: 15963291
references: Antimicrob Agents Chemother. 2005 Aug;49(8):3533-7
references: 16048977
references: J Med Microbiol. 2005 Dec;54(Pt 12):1183-7
references: 16278432
references: Emerg Infect Dis. 2006 Nov;12(11):1737-9
references: 17283625
references: Appl Environ Microbiol. 2008 Dec;74(23):7439-41
references: 18835997
references: Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents
references: 19136439
references: J Basic Microbiol. 2009 Dec;49(6):584-8
references: 19810044
references: Int J Antimicrob Agents. 2010 Jan;35(1):68-71
references: 19889520
references: Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):973-80
references: 21279730
references: Antimicrob Agents Chemother. 2011 Oct;55(10):4912-4
references: 21807978
references: J Med Microbiol. 2012 Jun;61(Pt 6):837-43
references: 22403140
references: Appl Environ Microbiol. 2012 Jun;78(12):4281-7
references: 22492436
references: Antimicrob Agents Chemother. 2013 Jan;57(1):603-5
references: 23089757
references: Environ Microbiol Rep. 2013 Feb;5(1):127-34
references: 23757141
references: PLoS One. 2013;8(7):e68484
references: 23894309
references: Appl Environ Microbiol. 2013 Dec;79(23):7142-9
references: 24038696
references: Int J Syst Evol Microbiol. 2014 Feb;64(Pt 2):449-55
references: 24158945
references: BMC Infect Dis. 2014;14:124
references: 24592922
references: PLoS One. 2014;9(6):e99826
references: 24937705
references: J Cyst Fibros. 2013 Mar;12(2):170-6
references: 22944724